Yasir Al-Wakeel – Biography
Last update: March 23, 2026Executive profile
Yasir was Chief Financial Officer & Head of Strategy at Neon Therapeutics, and Chief Financial Officer and Head of Corporate Development at Merrimack Pharmaceuticals. Yasir Al-Wakeel joined Casi Pharmaceuticals in 2021.
Yasir Al-Wakeel is currentlyDirector at MaxCyte - View - MaxCyte org chart
Director at Vicore Pharma - View - Vicore Pharma org chart
Create your alert
to follow the career of Yasir Al-Wakeel.
Education
Yasir Al-Wakeel has a Master of Arts in Theology from University of Cambridge and a Doctor Degree of Medicine and Surgery from University of Oxford.
They have also studied at University of Cambridge :
Find more alumni from University of Cambridge
They have also studied at University of Oxford :
Find more alumni from University of Oxford
More about Yasir Al-Wakeel
Selected links
Do you need to know more about Yasir Al-Wakeel? More results.
Participate
Social media
- Yasir Al-Wakeel on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Yasir Al-Wakeel
The colleagues of Yasir Al-Wakeel
Company Colleagues
- At MaxCyte, Yasir Al-Wakeel has 23 colleagues including Maher Masoud (CEO & President), Patrick Balthrop (Lead Director)…
- At Vicore Pharma, Yasir Al-Wakeel has 23 colleagues including Ahmed Mousa (CEO), Heidi Hunter (Director)…
Industry Colleagues
- In the Biotechnology industry, Yasir Al-Wakeel has 35,756 colleagues in 2,406 companies located in 42 countries. 16,877 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Yasir Al-Wakeel.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Yasir Al-Wakeel.
